New product-specific bioequivalence guidance Journal title: Generics and Biosimilars Initiative Journal Authors: Christoph Baumgärtel Subject(s):
Tyrosine kinase inhibitors becoming generic drugs – risks and chances from a regulatory perspective Journal title: Generics and Biosimilars Initiative Journal Authors: Niels Eckstein, Lea Röper, Bodo Haas, Henrike Potthast, Ulrike Hermes, Christoph Unkrig, Frauke Naum... Subject(s):
